Reply  by Peterson, Linda R. et al.
REPLY
We thank Dr. Iacobellis for his kind comments and the concerns
he raised regarding our study on the effects of obesity on left
ventricular (LV) structure and function in young and otherwise
healthy women (1). He raises some criticisms that are mostly
related to the health status of our subjects. We believe our obese
study subjects were “otherwise healthy” for the following reasons:
1) none of them had impaired fasting glucose levels (mean  SD
glucose: 84  9 mg/dl); 2) their mean 2-h glucose level during an
oral glucose tolerance test was 114  22 mg/dl within normal
limits; 3) none had low-density lipoprotein (LDL) or total
cholesterol levels that would be considered “high” per Adult
Treatment Panel (ATP) III guidelines (LDL: 117  24 mg/dl;
total cholesterol: 184  28 mg/dl); 4) their mean high-density
lipoprotein (HDL) (46  11 mg/dl) was similar to that of the
insulin-sensitive subjects in Dr. Iacobellis’s study (42.3  7.6
mg/dl) (2); 5) their mean triglyceride levels were normal (104 63
mg/dl); only two subjects had high triglyceride levels, and exclud-
ing data from these two subjects did not significantly change our
results; and 6) none had any nonlipid risk factors for coronary heart
disease listed by the ATP III, such as increased age, male gender,
family history of premature coronary heart disease, diabetes,
thrombogenic state, hypertension, or cigarette smoking. Thus, we
are hopeful that after this clarification, Dr. Iacobellis will agree that
these subjects can be considered “otherwise healthy,” and it is
unlikely that the presence of underevaluated co-morbidities could
explain the findings of our study.
Iacobellis et al. (2) found that among obese subjects, a subset of
those who were insulin resistant exhibited eccentric LV hypertro-
phy, and in another study obesity was associated with hyperkinetic
systole (3). In contrast, we found that the obese but otherwise
healthy women exhibited concentric LV remodeling and subtle
abnormalities in LV function (decreased diastolic and systolic
function by tissue Doppler imaging). Some of the apparent
discrepancies between the results of our studies may be attributable
to differences in echocardiographic equipment used; methods of
quantification of structure and function; and/or differences in
gender, age, and duration of obesity of the subjects (1–3). We
agree with Dr. Iacobellis that insulin resistance may affect LV
structure and function. One plausible scenario is that, as is the case
with hypertension, there is a continuum of obesity-related heart
disease, with concentric remodeling preceding eccentric hypertro-
phy and diastolic function preceding systolic dysfunction. If this
hypothesis is true, the findings of our study and those of Iacobellis
et al. (2,3) may in fact be complementary.
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